Cargando…
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease
OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240461/ https://www.ncbi.nlm.nih.gov/pubmed/35241631 http://dx.doi.org/10.1136/svn-2021-000939 |
_version_ | 1784737560560402432 |
---|---|
author | Nardi, Valentina Benson, John C Larson, Anthony S Brinjikji, Waleed Saba, Luca Meyer, Fredric B Lanzino, Giuseppe Lerman, Amir Savastano, Luis E |
author_facet | Nardi, Valentina Benson, John C Larson, Anthony S Brinjikji, Waleed Saba, Luca Meyer, Fredric B Lanzino, Giuseppe Lerman, Amir Savastano, Luis E |
author_sort | Nardi, Valentina |
collection | PubMed |
description | OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined. RESULTS: Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0–36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events. CONCLUSION: CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population. |
format | Online Article Text |
id | pubmed-9240461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-92404612022-07-20 Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease Nardi, Valentina Benson, John C Larson, Anthony S Brinjikji, Waleed Saba, Luca Meyer, Fredric B Lanzino, Giuseppe Lerman, Amir Savastano, Luis E Stroke Vasc Neurol Original Research OBJECT: We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC). METHODS: This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined. RESULTS: Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0–36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events. CONCLUSION: CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population. BMJ Publishing Group 2022-03-03 /pmc/articles/PMC9240461/ /pubmed/35241631 http://dx.doi.org/10.1136/svn-2021-000939 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Nardi, Valentina Benson, John C Larson, Anthony S Brinjikji, Waleed Saba, Luca Meyer, Fredric B Lanzino, Giuseppe Lerman, Amir Savastano, Luis E Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title | Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title_full | Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title_fullStr | Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title_full_unstemmed | Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title_short | Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
title_sort | carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240461/ https://www.ncbi.nlm.nih.gov/pubmed/35241631 http://dx.doi.org/10.1136/svn-2021-000939 |
work_keys_str_mv | AT nardivalentina carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT bensonjohnc carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT larsonanthonys carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT brinjikjiwaleed carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT sabaluca carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT meyerfredricb carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT lanzinogiuseppe carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT lermanamir carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease AT savastanoluise carotidarteryendarterectomyinpatientswithsymptomaticnonstenoticcarotidarterydisease |